Comparison between Bondada Engineering IPO and Mono Pharmacare IPO.
IPO Details
Bondada Engineering IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mono Pharmacare IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Bondada Engineering IPO is up to ₹40.56 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.07 Cr. The final issue price of Bondada Engineering IPO is ₹75.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.
IPO Timetable
Bondada Engineering IPO opens on Aug 18, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Bondada Engineering IPO and Mono Pharmacare IPO is Aug 22, 2023, and Aug 30, 2023, respectively.
| | Bondada Engineering IPO | Mono Pharmacare IPO |
|---|
| Issue Open | Aug 18, 2023 | Aug 28, 2023 |
| Issue Close | Aug 22, 2023 | Aug 30, 2023 |
| Basis Of Allotment (Tentative) | Aug 25, 2023 | Sep 04, 2023 |
| Initiation of Refunds (Tentative) | Aug 28, 2023 | Sep 05, 2023 |
| Credit of Share (Tentative) | Aug 29, 2023 | Sep 06, 2023 |
| Listing date (Tentative) | Aug 30, 2023 | Sep 07, 2023 |
Financials & KPIs
Bondada Engineering IPO P/E ratio is 6.56, as compared to Mono Pharmacare IPO P/E ratio of .
Shares Offered
In the Bondada Engineering IPO Retail Individual Investors (RII) are offered 27,04,000 shares while in Mono Pharmacare IPO retail investors are offered 27,04,000 shares. Qualified Institutional Buyers (QIB) are offered in Bondada Engineering IPO and 5,00,000 shares in Mono Pharmacare IPO.
| | Bondada Engineering IPO | Mono Pharmacare IPO |
|---|
| Market Maker Reservation | 2,88,000 shares | 2,76,000 shares |
| QIB | | 5,00,000 shares |
| NII | 27,04,000 shares | 22,60,000 shares |
| RII | 27,04,000 shares | 22,64,000 shares |
| Total | 54,08,000 shares | 50,24,000 shares |
Bids Received (Subscription)
Bondada Engineering IPO subscribed 107.76x in total, whereas Mono Pharmacare IPO subscribed 13.42x.
